Essity (ESSITY) UBS Global Consumer and Retail Conference summary
Event summary combining transcript, slides, and related documents.
UBS Global Consumer and Retail Conference summary
13 Mar, 2026Key business drivers and market positioning
Leading hygiene and health brands, including TENA and Tork, serve 1 billion people in 150 countries, holding #1 or #2 positions in most markets.
High unmet need in incontinence care due to low product usage rates among affected populations, supporting growth potential.
Four business areas: Health & Medical, Personal Care, Consumer Tissue, and Professional Hygiene, with focus on high-margin segments.
Strategic reduction in exposure to less profitable Consumer Tissue, while expanding in high-yielding categories and geographies.
Mega trends such as aging population, increased hygiene awareness, and rising disposable income drive category growth.
Strategic initiatives and acquisitions
Strategy centers on innovation, efficiency, and prioritizing high-yield segments and attractive geographies.
Acquired Edgewell's feminine care business in North America, including Carefree, Stayfree, O.b., and Playtex brands, for USD 340m, doubling Personal Care sales in the U.S.
Integration of Edgewell acquisition aims to strengthen the Personal Care business in North America.
Reorganization to decentralize decision-making and sharpen focus on profitable segments, with SG&A cost-saving program to be achieved by end of 2026.
SG&A savings and organizational reshaping to unlock resources for profitable growth.
Financial performance and targets
2025 net sales reached SEK 138bn, with EBITA (excl. IAC) at SEK 19.6bn and 36,000 employees globally.
2025 EBITA margin (excl. IAC) at 14.7%, EPS up 14% to SEK 4.69m, and strong cash flow.
Annual organic sales growth target above 3% and EBITA margin target above 15%.
EPS grew 58% since 2017, reaching SEK 19.4 per share in 2025 (CAGR 6%).
Proposed 2025 dividend of SEK 8.75 per share, up 6% year-over-year and 52% since 2018.
Latest events from Essity
- Aiming for 3%+ organic growth and 15%+ margins, driven by innovation, brands, and efficiency.ESSITY
CMD 202417 Mar 2026 - Targets raised: organic sales growth >3%, EBITA margin >15%, SEK 3bn buyback, focus on high-margin growth.ESSITY
Investor Update3 Feb 2026 - Record EBITA and margin gains, new growth targets, and a SEK 3bn buyback boost value.ESSITY
Q2 20243 Feb 2026 - Portfolio shift and strong margins drive growth and future flexibility.ESSITY
21st Annual dbAccess Global Consumer Conference 202431 Jan 2026 - Profitability and margins rose in Q4 2025, supported by acquisitions and cost-saving actions.ESSITY
Q4 202522 Jan 2026 - Record cash flow, margin gains, and reduced net debt mark a robust Q3 2024.ESSITY
Q3 202418 Jan 2026 - Record sales, profit, and higher dividend in 2024, with focus on growth and innovation for 2025.ESSITY
Q4 202410 Jan 2026 - Q1 2025 saw sales growth, strong cash flow, and a new SEK 3bn share buyback program.ESSITY
Q1 202521 Dec 2025 - Record profits, innovation, and high-margin growth drive strong 2024 results and future targets.ESSITY
UBS Global Consumer and Retail Conference 202520 Dec 2025